Affinity Biosensors (Archimedes product portfolio) is Drug Delivery in United States that focus on developer business. Founded in 2010. They cover business area such as developer, injectable pharmaceutical, Santa Barbara, California, protein-base pharmaceutical, MEMS-base microfluidic, particle mass measurement.
2010
( 14 years old in 2024 )
Developer
-
Suite 101
222 East Canon Perdido Street
Santa Barbara, CA
United States
Private
developerinjectable pharmaceuticalSanta BarbaraCaliforniaprotein-base pharmaceuticalMEMS-base microfluidicparticle mass measurement
* We use standard office opening hours in near Affinity Biosensors (Archimedes product portfolio)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Affinity Biosensors (Archimedes Product Portfolio) is Drug Delivery business from United States that founded in 2010 (14 years old in 2024), Affinity Biosensors (Archimedes product portfolio) business is focusing on Developer.
Affinity Biosensors (Archimedes product portfolio) headquarter office and corporate office address is located in Suite 101 222 East Canon Perdido Street Santa Barbara, CA United States.
Affinity Biosensors (Archimedes product portfolio) was founded in United States.
In 2024, Affinity Biosensors (Archimedes product portfolio) is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Affinity Biosensors (Archimedes product portfolio), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
